Challenge:
A biotech company developing improved versions of available chemotherapy drugs approached Alacrita for indication strategy support, seeking to sanity check and refine its current clinical development strategy and products' differentiation and clinical placement, as well as brainstorm other avenues to pursue.
Solution:
One of Alacrita's highly experienced clinical oncologists provided support on an ad-hoc basis. In the first phase of work our consultant reviewed documentation outlining the company's clinical development strategy and provided a framework to exclude / include specific opportunities based on scientific and clinical rationale, as well as market drivers. The consultant was then brought on board under a retainer agreement to provide ongoing support.
Clinical Development Support
Our drug development consultants each bring an average of 20 years of industry experience and wisdom to our clients' program teams. Many have made significant contributions to the development of launched products and have held global responsibilities for marketed medicines. With Alacrita, you can access high-caliber, clinical development experts with proven track records and precisely relevant expertise. Whether you need to rapidly augment your existing capabilities, move past a development or regulatory hurdle with minimal delay, or obtain high-level strategic guidance, we have the experience and personnel to help you.
Back